Suprofen

CHEMBL956 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
260.3 g/mol
LogP
3.3
Phase
4

Suprofen is a non-steroidal anti-inflammatory drug (NSAID) of the propionic acid class, formerly used systemically for pain and inflammation and now used as a topical ophthalmic NSAID to prevent surgically induced miosis during cataract surgery and relieve postoperative ocular inflammation. It inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis in the anterior chamber that mediates intraoperative pupillary constriction. Systemic suprofen was withdrawn due to flank pain syndrome.

आणविक भार

260.3100 g/mol

LogP

3.30

TPSA

82.60 Ų

लिपिंस्की RO5

उत्तीर्ण

क्रिया का तंत्र

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

तंत्र

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1

InChI

InChI=1S/C14H12O3S/c1-9(14(16)17)10-4-6-11(7-5-10)13(15)12-3-2-8-18-12/h2-9H,1H3,(H,16,17)

Molecular Formula

C14H12O3S

HBD / HBA

1 / 4

घूर्णनीय बंधन

4

भारी परमाणु

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

Suprofen is a non-steroidal anti-inflammatory drug (NSAID) of the propionic acid class, formerly used systemically for pain and inflammation and now used as a topical ophthalmic NSAID to prevent surgically induced miosis during cataract surgery and relieve postoperative ocular inflammation. It inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis in the anterior chamber that mediates intraoperative pupillary constriction. Systemic suprofen was withdrawn due to flank pain syndrome.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Suprofen is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL956. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5359. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.